Table 4.
FSH is positively associated with risks of MetS biomarkers.
| Components of MetS, n(%) | Q1 n = 79 | Q2 n = 79 | Q3 n = 78 | p value |
|---|---|---|---|---|
| Central obesity | 66(86.84) | 57(73.08)∗ | 68(90.67)$$ | 0.009 |
| Raised TG | 14(17.72) | 9(11.39) | 21(26.92)$ | 0.043 |
| Low HDL-C | 31(39.24) | 31(39.24) | 34(43.59) | 0.815 |
| Raised FPG | 32(40.51) | 34(43.04) | 38(48.72) | 0.570 |
| Raised BP | 33(41.77) | 36(45.57) | 49(62.82)∗∗$ | 0.019 |
| Mets | 27(34.17) | 26(32.91) | 38(48.72)∗ | 0.043 |
Data are expressed as number with proportion for categorical variables. Pearson chi-squared test was used in the comparison for dichotomous variables. ∗p < 0.05, ∗p < 0.01 vs Q1 group; $p < 0.05, $$p < 0.01 vs. Q2 group.